Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

In the Wake of Dobbs v. Jackson Women’s Health Organization

Mary Beth Nierengarten  |  Issue: May 2023  |  May 10, 2023

She acknowledges, however, that clinicians may be hesitant to provide patients of childbearing age with medications that may result in harm to a baby who is ultimately born or to a pregnancy that ends in a miscarriage. It is conceivable, she says, that a clinician could be subject to liability for medical malpractice or other claims depending on their state’s law (e.g., wrongful death) and may, therefore, want to consult a lawyer licensed in their state with questions about a specific situation.

To avoid this situation, Cuoghi Edens, MD, assistant professor of internal medicine and pediatrics at University of Chicago Medicine, says documentation is critical, particularly in states with ambiguous abortion laws where, for example, definitions of aid and abet are gray.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Documenting conversations with patients and families about the risks of pregnancy and recommendations for contraceptive use protects rheumatologists from potential liability in the future, she says, adding that such documentation can help the patient’s other care providers as well. For patients, documentation is helpful because they can access their medical records to review information discussed during their clinical visit.

In general, Ms. Hill emphasized that physicians should familiarize themselves with the rules of their state about what sorts of conduct they are required (or not required) to report to law enforcement or other state agencies. For example, she cited a scenario in which a physician practicing in a state with restrictive abortion laws refers a patient for an abortion to a state without an abortion ban. In this case, physicians “should consult legal counsel to ensure they are not at risk of violating any state laws,” she says, adding that most states don’t forbid this, but “it’s better to be safe, especially given that most abortion restrictions carry criminal penalties.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Going Forward

Dr. Edens

Stressing that rheumatologists should not change treatment plans or veer from evidence-based practice based on the recent ruling, Dr. Edens put a positive spin on what the ruling has offered rheumatologists.

“The Supreme Court ruling has brought an often taboo subject to the forefront of rheumatology and demonstrated that reproductive health is essential to rheumatology care,” she says. “The effect of the lack of access to abortion for patients on medications that cause congenital malformations or who have severe, organ-threatening rheumatic disease is obvious.”

She emphasizes that rheumatologists who care for patients of child-bearing age should evaluate their patients’ sexual activity and pregnancy intentions at every visit and when new medications are prescribed. She cautions against assuming a patient’s primary care provider is discussing these issues with them, and emphasizes that patients want their rheumatologist to be involved in their reproductive health.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:EthicsLegal UpdatesProfessional Topics Tagged with:abortionDobbs v. Jackson Women's Health Organization

Related Articles

    Speak Out Rheum: To Prescribe Is Humane (Unless You’re In Texas)

    November 7, 2022

    You are a rheumatologist in Texas. You are very well trained. Your mentors included some of the leaders in rheumatology, and you are respected by your colleagues and your patients. You know the devastation of untreated rheumatoid arthritis and lupus. A young woman with recent onset of systemic lupus erythematosus is your new patient. You…

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Contraception, Abortion & Rheumatic Disease after Dobbs

    December 12, 2022

    PHILADELPHIA—As rheumatologists, we care for patients who may or may not want to become pregnant. We aren’t obstetricians or gynecologists, but several of the drugs we prescribe for active rheumatic disease can negatively affect pregnancy outcomes. It’s imperative we understand how to effectively counsel our patients with rheumatic disease on the risks and benefits of…

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences